Latest total assets for BLPH: $5M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Bellerophon Therapeutics (BLPH) currently reports a total assets of $5M as of September 2023. That compares with $13M in the prior-year period — down 60.5% year over year. Use the charts on this page to explore Bellerophon Therapeutics's total assets history and peer comparisons.
Bellerophon Therapeutics's total assets decreased from $13M to $5M — a 60.5% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Bellerophon Therapeutics reported $5M in total assets as of September 2023. That compares with $13M in the prior-year period — down 60.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bellerophon Therapeutics, and consider following BLPH for alerts when major investors trade the stock.
Bellerophon Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLPH with unrelated industries.